A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Plaque Psoriasis
Related studies linked through entity extraction aliases.
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study
- Status
- UNKNOWN
- Phase
- N/A
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)
- Status
- COMPLETED
- Phase
- PHASE2
Guselkumab Immunogenetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis
- Status
- UNKNOWN
- Phase
- PHASE4
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
- Status
- RECRUITING
- Phase
- PHASE4
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
- Status
- TERMINATED
- Phase
- PHASE4
Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
- Status
- COMPLETED
- Phase
- N/A
Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE4
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1